(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The Division of Dermatology is home to pediatric dermatology specialists who are prepared to care for your child's unique needs. Learn more about our faculty and staff.
Kara N. Shah, MD, PhD Director, Division of Dermatology 513-636-4215 firstname.lastname@example.org
Director, Division of Dermatology
Associate Professor, UC Department of Pediatrics
Atopic dermatitis; psoriasis; genetic skin diseases (genodermatoses); hemangiomas and vascular malformations; neonatal dermatology; cutaneous lymphoma; hair and nail disorders; moles and pigmented lesions
Dr. Shah is the director of the Division of Dermatology at Cincinnati Children's and an associate professor of pediatrics and dermatology at the University of Cincinnati College of Medicine. She has extensive experience with resident and fellow education via supervision of trainees in outpatient clinics, on inpatient consultative rounds, in surgical and laser procedures, and in didactic activities. She is building clinical and research programs in atopic dermatitis, pigmented lesions and cutaneous lymphoma, genodermatoses, and wound care. Dr. Shah will actively supervise fellow trainees in the outpatient clinics as well as on the inpatient consultation service and on clinical research projects. She holds board certification in pediatrics, dermatology, and pediatric dermatology.
MD: University of Maryland, 1992.
PhD: University of Maryland (Molecular and Cell Biology), 2000.
Residency: Pediatrics, Texas Children's Hospital, 2003; Dermatology, Hospital of the University of Pennsylvania, 2006.
Fellowship: Clinical Fellow, Pediatric Dermatology, The Children's Hospital of Philadelphia, 2006-2007.
Certification: American Board of Pediatrics, 2003; American Board of Dermatology, 2006; Subspecialty Board in Pediatric Dermatology, American Board of Dermatology, 2008.
Shah KN. The diagnostic and clinical significance of café-au-lait macules. Pediatr Clin North Am. 2010 Oct;57(5):1131-53.
Shah KN. The risk of melanoma and neurocutaneous melanosis associated with congenital melanocytic nevi. Semin Cutan Med Surg.2010 Sep;29(3):159-64.
Yan AC, Honig PJ, Ming ME, Weber J, Shah KN. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. Arch Dermatol. 2010 Jan;146(1):57-62.
Shah KN, Honig PJ, Yan AC. "Urticaria multiforme": a case series and review of acute annular urticarial hypersensitivity syndromes in children. Pediatrics. 2007 May;119(5):e1177-83.
Shah KN, Yan AC. Low but detectable serum levels of tacrolimus seen with the use of very dilute, extemporaneously compounded formulations of tacrolimus ointment in the treatment of patients with Netherton syndrome. Arch Dermatol. 2006 Oct;142(10):1362-3.
Shah KN, Fried RG. Factitial dermatoses in children. Curr Opin Pediatr. 2006 Aug;18(4):403-9.
Yan AC, Smolinski KN. Melanocytic nevi: challenging clinical situations in pediatric dermatology. Adv Dermatol. 2005;21:65-80.
Smolinski KN, Yan AC. Hemangiomas of infancy: clinical and biological characteristics. Clin Pediatr (Phila). 2005 Nov-Dec;44(9):747-66.
Smolinski KN, Yan AC. How and when to treat molluscum contagiosum and warts in children. Pediatr Ann. 2005 Mar;34(3):211-21.
Smolinski KN, Shah SS, Honig PJ, Yan AC. Neonatal cutaneous fungal infections. Curr Opin Pediatr. 2005 Aug;17(4):486-93.
Fernanda Bellodi Schmidt, MD Clinical Director, Division of Dermatology 513-636-4215 email@example.com
Clinical Director, Division of Dermatology
Assistant Professor, UC Department of Pediatrics
Moles and other pigmented lesions; eczema and atopic dermatitis; psoriasis; acne; birthmarks; cutaneous drug reactions; other common skin diseases of childhood and adolescence.
MD: Universidade Estadual de Campinas, Unicamp, Brazil, 2007.
Residency: Dermatology, Universidade Estadual de Campinas, Unicamp, Brazil, 2012; Pediatrics, Preliminary year, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2015.
Fellowship: Pediatric Dermatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2014.
Bellodi Schmidt F, Shah KN. Beyond Psoriasis: Novel Uses for Biologic Response Modifiers in Pediatric Dermatology. Pediatr Dermatol. Accepted.
Bellodi Schmidt F, Shah KN. Biologic response modifiers and pediatric psoriasis. Pediatr Dermatol. 2015 May;32(3):303-2.
Bonini FK, Bellodi FS, Souza EM. Propranolol treatment for hemangioma of infancy. An Bras Dermatol. 2011 Jul-Aug;86(4):763-6.
Faye Eifert, MSN, APRN, CNP Nurse Practitioner, Division of Dermatology 513-636-4215 firstname.lastname@example.org
Nurse Practitioner, Division of Dermatology
MSN: University of Cincinnati, Cincinnati, OH, 2015.
Certification: AANP, FNP-C, 2015.
Anne W. Lucky, MD Medical Director, Epidermolysis Bullosa Center 513-636-2009
Medical Director, Epidermolysis Bullosa Center
Volunteer Professor of Dermatology and Pediatrics, UC Department of Pediatrics
All aspects of pediatric dermatology, especially acne
Dr. Anne Lucky is a pediatric dermatologist who is currently working at both Cincinnati Children’s and in private practice. She obtained her medical degree from the Yale University School of Medicine. She has a long academic career in laboratory and clinical practice with over 200 peer-reviewed publications, as well as many reviews, book chapters, and national and international invited lectures.
She is the director of the Epidermolysis Bullosa Center and a founding member of the Hemangioma and Vascular Malformation Center. She holds board certification in pediatric dermatology, pediatrics, pediatric endocrinology and dermatology and has served as the president of the Society for Pediatric Dermatology and the American Board of Dermatology. She is active in the Hemangioma Investigator Group (HIG) which a multi-institutional research consortium to provide quality data on the safety and effectiveness of the novel application of therapeutics in infantile hemangiomas. Dr. Lucky’s specialties include all aspects of pediatric dermatology.
BA: Pembroke College in Brown University, Providence, RI, 1966.
MD: Yale University School of Medicine, New Haven, CT, 1970.
Residency: Children's Hospital Medical Center, Boston, MA, 1973; Yale University School of Medicine, New Haven, CT, 1981.
Fellowship: Human Genetics and Pediatrics, Yale University School of Medicine, New Haven, CT, 1974; Clinical Associate (Endocrinology), Reproduction Research Branch of the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md., 1976.
Certification: Pediatrics, 1975; Pediatric Endocrinology, 1978; Dermatology, 1981.
Hinze CH, Lucky AW, Bove KE, Marsh RA, Bleesing JH, Passo MH. Leukocyte adhesion deficiency type 1 presenting with recurrent pyoderma gangrenosum and flaccid scarring. Pediatr Dermatol. 2010 Sep-Oct;27(5):500-3.
Goldschneider K, Lucky AW, Mellerio JE, Palisson F, del Carmen Viñuela Miranda M, Azizkhan RG. Perioperative care of patients with epidermolysis bullosa: proceedings of the 5th international symposium on epidermolysis bullosa, Santiago Chile, December 4-6, 2008. Paediatr Anaesth. 2010 Sep;20(9):797-804.
Abdulla F, Sheth AP, Lucky AW. Hemorrhagic, bullous Henoch Schonlein purpura in a 16-year-old girl with previously undiagnosed dominant dystrophic epidermolysis bullosa. Pediatr Dermatol. 2010 Mar-Apr;27(2):203-4.
Goldschneider KR, Lucky AW. Pain management in epidermolysis bullosa. Dermatol Clin. 2010 Apr;28(2):273-82, ix. Review.
Lomenick JP, Reifschneider KL, Lucky AW, Adams D, Azizkhan RG, Woo JG, Backeljauw PF. Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol. 2009 Mar;145(3):262-6.
Biro FM, Huang B, Daniels SR, Lucky AW. Pubarche as well as thelarche may be a marker for the onset of puberty. J Pediatr Adolesc Gynecol. 2008 Dec;21(6):323-8.
Lucky AW, Koltun W, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J. A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment. Cutis. 2008 Aug;82(2):143-50.
Perman M, Sheth P, Lucky AW. Progressive macular hypomelanosis in a 16-year old. Pediatr Dermatol. 2008 Jan-Feb;25(1):63-5.
Gupta J, Grube E, Ericksen MB, Stevenson MD, Lucky AW, Sheth AP, Assa'ad AH, Khurana Hershey GK. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol. 2008 Mar;121(3):725-730.e2.
Stehr W, Farrell MK, Lucky AW, Johnson ND, Racadio JM, Azizkhan RG. Non-endoscopic percutaneous gastrostomy placement in children with recessive dystrophic epidermolysis bullosa. Pediatr Surg Int. 2008 Mar;24(3):349-54.
Susan F. MacPherson, MSN, APRN, CNP Certified Nurse Practitioner, Division of Dermatology 513-636-4215 email@example.com
Certified Nurse Practitioner, Division of Dermatology
MSN: Mount St. Joseph, Cincinnati, OH, 2006.
MSN: Northern Kentucky University, Highland Heights KY, 2013.
Certification: ANCC PNP-PC, 2013.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center. All rights reserved.